INVANZ (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the INVANZ drug offered from Merck Sharp & Dohme Corp.. This Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: ertapenem sodium
SUBSTANCE NAME: ERTAPENEM SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2001-11-21
END MARKETING DATE: 0000-00-00


INVANZ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINVANZ from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2001-11-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-3843_424b0d88-6662-498a-9aff-68b7bba48d14
PRODUCT NDC: 0006-3843
APPLICATION NUMBER: NDA021337

Other ERTAPENEM SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.INVANZ